Colin T. Gillespie
Papers
4
Total Citations
192
H-Index
3
About
Dr. Colin T. Gillespie is a leading innovator in interventional pulmonology, specializing in the development and validation of robotic bronchoscopic systems for diagnosing peripheral pulmonary lesions. His major contributions center on rigorous, preclinical assessments of robotic platforms, demonstrating their potential to overcome the clinical challenges of reaching and biopsying small, hard-to-access lung tumors. Dr. Gillespie’s landmark REACH Assessment (2018, 113 citations) established foundational metrics for robotic endoscopic maneuverability within the airway. He further advanced the field with the ACCESS Study (2019, 57 citations), which quantified the accuracy of robotic systems in cadaver models with simulated tumor targets, providing critical evidence for their precision and safety. This work directly addresses a key limitation of conventional bronchoscopy, paving the way for improved diagnostic yields in lung cancer. Through these high-impact studies, Dr. Gillespie has become a pivotal figure in translating robotic technology from engineering concept to clinical reality, setting the stage for future human trials and ultimately aiming to enhance early detection and treatment outcomes for patients with pulmonary lesions.
Research Focus
Key Achievements
Top Papers
- 1Robotic Endoscopic Airway Challenge: REACH Assessment113 citations · 2018
- 2
- 3Robotic Endoscopic Airway Challenge: Reach Assessment19 citations · 2017
- 4